Last updated 57 days ago

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

116 patients around the world

Available in Argentina, Chile, United States

Sanofi

7Research sites

116Patients around the world

This study is for people with

Lupus

Systemic lupus erythematosus

Requirements for the patient

To 70 Years

All Gender

Medical requirements

Sites

Sala de Primeros Auxilios Alberto Mignaburu - Berazategui, Prov Buenos Aires

Recruiting

Av. Antartida Argentina entre calle 257 y camino Gral Belgrano S/N, Berazategui Buenos Aireshttps://www.facebook.com/fundacionrespirarsalud

STAT Research - CABA

Recruiting

Av. Callao 875, CABA, Buenos Aires

DOM Centro de Reumatología - CABA

Recruiting

Ayacucho 1246, CABA, Buenos Aires

Clínica Adventista Belgrano - CABA - Buenos Aires

Recruiting

Estomba 1710, CABA, Buenos Aireshttps://clinicaadventista.org/

Centro de Investigaciones Médicas Tucumán

Recruiting

Lavalle 506, T4000 San Miguel de Tucumán, Tucumán, Argentina

Fundación CIDEA - Buenos Aires

Paraguay 2035, C1121ABE Cdad. Autónoma de Buenos Aires, Argentinahttps://fundacioncidea.org.ar/

Centro Paulista de Investigação Clínica - CEPIC

Recruiting

R. Moreira e Costa, 342 - Ipiranga, São Paulo - SP, 04266-010

StudyAPATURA

SponsorSanofi

Study typeInterventional

Conditions

Systemic lupus erythematosus

Requirements

To 70 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05039840